The Japan orphan drugs market is anticipated to grow at a compound annual growth rate (CAGR) of 10.26% from 2024 to 2032. Key factors fueling this growth include the increasing prevalence of rare diseases without available treatments and enhanced access to healthcare services. https://www.imarcgroup.com/japan-orphan-drugs-market